1
/
of
1
Elabscience
SKU:PKSQ050026
Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag)
Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag), a cutting-edge product designed to meet the demands of advanced research in the field of immunology. This protein, derived from the cynomolgus macaque species, offers a highly purified and bioactive solution for the study of immune checkpoint pathways.
The Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag) is produced using state-of-the-art recombinant DNA technology, ensuring a high level of purity and consistency. The protein is expressed with a histidine (His) tag, facilitating easy purification and subsequent downstream applications.
This protein is a crucial component in the study of immune regulation, particularly in the context of cancer immunotherapy. PD-L2, also known as B7-DC or CD273, is a key immune checkpoint molecule that plays a vital role in modulating T-cell responses. By binding to its receptor PD-1 on T-cells, PD-L2 inhibits T-cell activation, thereby suppressing immune responses. Understanding the mechanisms underlying this interaction is essential for the development of novel immunotherapeutic strategies.
The Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag) offers researchers a reliable tool to investigate the intricate details of the PD-L2/PD-1 pathway. Its high purity and bioactivity ensure accurate and reproducible results, enabling researchers to gain valuable insights into immune checkpoint regulation.
This product is provided in lyophilized form, ensuring long-term stability and ease of storage. It can be reconstituted in a suitable buffer for immediate use in a variety of applications, including protein-protein interaction studies, receptor-ligand binding assays, and functional assays.
In summary, the Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag) is a superior research tool that empowers scientists to delve into the intricate workings of immune checkpoint pathways. With its high purity, bioactivity, and ease of use, this protein is an indispensable asset for advancing our understanding of immunology and developing innovative therapeutic interventions.
The Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag) is produced using state-of-the-art recombinant DNA technology, ensuring a high level of purity and consistency. The protein is expressed with a histidine (His) tag, facilitating easy purification and subsequent downstream applications.
This protein is a crucial component in the study of immune regulation, particularly in the context of cancer immunotherapy. PD-L2, also known as B7-DC or CD273, is a key immune checkpoint molecule that plays a vital role in modulating T-cell responses. By binding to its receptor PD-1 on T-cells, PD-L2 inhibits T-cell activation, thereby suppressing immune responses. Understanding the mechanisms underlying this interaction is essential for the development of novel immunotherapeutic strategies.
The Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag) offers researchers a reliable tool to investigate the intricate details of the PD-L2/PD-1 pathway. Its high purity and bioactivity ensure accurate and reproducible results, enabling researchers to gain valuable insights into immune checkpoint regulation.
This product is provided in lyophilized form, ensuring long-term stability and ease of storage. It can be reconstituted in a suitable buffer for immediate use in a variety of applications, including protein-protein interaction studies, receptor-ligand binding assays, and functional assays.
In summary, the Recombinant Cynomolgus PD-L2/B7-DC/CD273 Protein (His Tag) is a superior research tool that empowers scientists to delve into the intricate workings of immune checkpoint pathways. With its high purity, bioactivity, and ease of use, this protein is an indispensable asset for advancing our understanding of immunology and developing innovative therapeutic interventions.
Share
